Renalytix Plc

(LSE) RENX

Current Price£0.02

Market Cap£10.05M

Since IPO (2018)-98%

5 Year-100%

1 Year-70%

1 Month+18%

Renalytix Plc Financials at a Glance

Market Cap

£10.05M

Revenue (TTM)

$2.37M

Net Income (TTM)

-$23.43M

EPS (TTM)

£0.00

P/E Ratio

-0.16

Dividend

£0.00

Beta (Volatility)

0.06 (Low)

Dividend

£0.00

Beta (Volatility)

0.06 (Low)

Price

£0.02

Volume

204,045

Open

£0.02

Price

£0.02

Volume

204,045

Open

£0.02

Previous Close

£0.02

Daily Range

£0.02 - £0.02

52-Week Range

£0.02 - £0.16

Estimated Earnings Date

Nov 3, 2026

Dividend

£0.00

Beta (Volatility)

0.06 (Low)

Price

£0.02

Volume

204,045

Open

£0.02

Previous Close

£0.02

Daily Range

£0.02 - £0.02

52-Week Range

£0.02 - £0.16

Estimated Earnings Date

Nov 3, 2026

RENX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Renalytix Plc

Industry

Health Care Technology

Sector

Health Care

Employees

CEO

James Renwick McCullough, MBA

Website

renalytix.com

Headquarters

New York City, NY 10036, US

RENX Financials

Key Financial Metrics (TTM)

Gross Margin

6.82%

Operating Margin

-1293.49%

Net Income Margin

-1461.60%

Return on Equity

-631.25%

Return on Capital

-1323.08%

Return on Assets

-419.67%

Earnings Yield

-6.25%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£10.05M

Shares Outstanding

437.02M

Volume

204.04K

Avg. Volume

709.23K

Financials (TTM)

Gross Profit

$468.00K

Operating Income

-$19.19M

EBITDA

-$23.07M

Operating Cash Flow

-$23.02M

Capital Expenditure

-$4.00K

Free Cash Flow

-$23.03M

Cash & ST Invst.

$6.20M

Total Debt

$5.80M

Renalytix Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$729.00K

+2.8%

Gross Profit

$398.00K

+73.8%

Gross Margin

54.60%

N/A

Market Cap

£10.05M

N/A

Market Cap/Employee

£98.54K

N/A

Employees

102

N/A

Net Income

-$3.88M

+54.2%

EBITDA

-$7.50M

+8.8%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Total Cash

$6.20M

+31.8%

Total Debt

$5.80M

-38.4%

Accounts Receivable

$1.30M

+134.7%

Inventory

$300.00K

N/A

Long Term Debt

$5.60M

+14.5%

Short Term Debt

$200.00K

-95.6%

Return on Assets

-4.20%

N/A

Return on Invested Capital

8.40%

N/A

Free Cash Flow

-$6.50M

+18.0%

Operating Cash Flow

-$6.50M

+18.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

COG.LCambridge Cognition Holdings Plc

COG.LCambridge Cognition Holdings Plc£0.32-3.03%

FDBK.LFeedback plc

FDBK.LFeedback plc£0.07-1.41%

IHC.LInspiration Healthcare Group plc

IHC.LInspiration Healthcare Group plc£0.21+2.44%

NCYT.LNovacyt S.A.

NCYT.LNovacyt S.A.£0.35+0.16%

SBTX.LSkinBioTherapeutics Plc

SBTX.LSkinBioTherapeutics Plc£0.10-2.26%

SAR.LSareum Holdings plc

SAR.LSareum Holdings plc£0.20-3.33%

POLB.LPoolbeg Pharma PLC

POLB.LPoolbeg Pharma PLC£0.07-0.16%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$37.65+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.13-0.00%

METUDirexion Shares ETF Trust - Direxion Daily Meta Bull 2x Shares

METUDirexion Shares ETF Trust - Direxion Daily Meta Bull 2x Shares$23.00+0.14%

OKLLTidal Trust II - Defiance Daily Target 2x Long Oklo ETF

OKLLTidal Trust II - Defiance Daily Target 2x Long Oklo ETF$4.97+0.01%

SGOViShares Trust - iShares 0-3 Month Treasury Bond ETF

SGOViShares Trust - iShares 0-3 Month Treasury Bond ETF$100.39+0.00%

TAT&T

TAT&T$20.91+0.01%

NVDANvidia

NVDANvidia$195.28-0.02%

Questions About RENX

What is the current price of Renalytix Plc?

Renalytix Plc is trading at £0.02 per share.

What is the 52-week range for Renalytix Plc?

Over the past 52 weeks, Renalytix Plc has traded between £0.02 and £0.16.

How much debt does Renalytix Plc have?

As of the most recent reporting period, Renalytix Plc reported total debt of $6.55M.

How much cash does Renalytix Plc have on hand?

Renalytix Plc reported $7.35M in cash and cash equivalents in its most recent financial results.

What is Renalytix Plc’s dividend yield?

Renalytix Plc does not currently have a dividend yield.

Renalytix Plc

Renalytix Plc Financials at a Glance

RENX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Renalytix Plc

RENX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Renalytix Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RENX

What is the current price of Renalytix Plc?

What is the 52-week range for Renalytix Plc?

How much debt does Renalytix Plc have?

How much cash does Renalytix Plc have on hand?

What is Renalytix Plc’s dividend yield?

Premium Investing Services